Litcius/Paper detail

Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis

Qiyan Zheng, Huisheng Yang, Luying Sun, Ruojun Wei, Xinwen Fu, Ya‐Hui Wang, Yishan Huang, Yu Ning Liu, Wei Jing Liu

2020Pharmacological Research68 citationsDOI

Topics & Concepts

MedicineDarbepoetin alfaAnemiaKidney diseaseInternal medicinePlaceboDialysisGastroenterologyErythropoietinCochrane LibraryEpoetin alfaRandomized controlled trialPathologyAlternative medicineErythropoietin and Anemia TreatmentDialysis and Renal Disease ManagementIron Metabolism and Disorders
Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis | Litcius